NCT00812955
Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides
See it on ClinicalTrials.gov ↗474 people
53.2%
46.8%
252 womenmiddle line = equal numbers222 men
- Phase
- PHASE3
- Paid for by
- AstraZeneca
- Finished
- 2009-06
- Health conditions
- Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 56.6 years
- Age 65+
- 21.3%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant or lactating women, or women intending to become pregnant.”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnant or lactating women, or women intending to become pregnant.”
- No diabetes
Women with diabetes were turned away.
“Participants with diabetes mellitus that is poorly controlled.”
Study titles and rules are shown in their original English.